Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA STRIDES PHARMA SCIENCE ALEMBIC PHARMA/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 32.2 -1,455.3 - View Chart
P/BV x 4.4 3.3 134.7% View Chart
Dividend Yield % 0.8 0.2 424.9%  

Financials

 ALEMBIC PHARMA   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
STRIDES PHARMA SCIENCE
Mar-23
ALEMBIC PHARMA/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs792392 202.0%   
Low Rs463263 175.9%   
Sales per share (Unadj.) Rs287.6408.5 70.4%  
Earnings per share (Unadj.) Rs17.4-25.6 -68.0%  
Cash flow per share (Unadj.) Rs31.41.4 2,296.2%  
Dividends per share (Unadj.) Rs8.001.50 533.3%  
Avg Dividend yield %1.30.5 278.5%  
Book value per share (Unadj.) Rs222.3242.8 91.6%  
Shares outstanding (eoy) m196.5690.30 217.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.20.8 272.0%   
Avg P/E ratio x36.1-12.8 -281.4%  
P/CF ratio (eoy) x20.0239.6 8.3%  
Price / Book Value ratio x2.81.4 209.2%  
Dividend payout %46.0-5.9 -783.8%   
Avg Mkt Cap Rs m123,40229,603 416.9%   
No. of employees `000NANA-   
Total wages/salary Rs m11,6917,320 159.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,52636,884 153.3%  
Other income Rs m301,352 2.2%   
Total revenues Rs m56,55738,236 147.9%   
Gross profit Rs m6,772830 816.1%  
Depreciation Rs m2,7542,433 113.2%   
Interest Rs m5022,611 19.2%   
Profit before tax Rs m3,546-2,862 -123.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m126-553 -22.8%   
Profit after tax Rs m3,420-2,309 -148.1%  
Gross profit margin %12.02.2 532.5%  
Effective tax rate %3.619.3 18.4%   
Net profit margin %6.1-6.3 -96.6%  
BALANCE SHEET DATA
Current assets Rs m29,13931,353 92.9%   
Current liabilities Rs m16,40829,902 54.9%   
Net working cap to sales %22.53.9 572.7%  
Current ratio x1.81.0 169.4%  
Inventory Days Days1071 13.6%  
Debtors Days Days7129 5.3%  
Net fixed assets Rs m31,49831,300 100.6%   
Share capital Rs m393903 43.5%   
"Free" reserves Rs m43,31221,025 206.0%   
Net worth Rs m43,70521,928 199.3%   
Long term debt Rs m011,398 0.0%   
Total assets Rs m60,63763,734 95.1%  
Interest coverage x8.1-0.1 -8,408.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.6 161.1%   
Return on assets %6.50.5 1,362.9%  
Return on equity %7.8-10.5 -74.3%  
Return on capital %9.3-0.8 -1,231.7%  
Exports to sales %46.446.7 99.4%   
Imports to sales %12.10-   
Exports (fob) Rs m26,21017,213 152.3%   
Imports (cif) Rs m6,846NA-   
Fx inflow Rs m26,21018,113 144.7%   
Fx outflow Rs m6,846672 1,019.4%   
Net fx Rs m19,36417,442 111.0%   
CASH FLOW
From Operations Rs m7,240444 1,630.1%  
From Investments Rs m-4,4763,025 -148.0%  
From Financial Activity Rs m-2,620-2,139 122.5%  
Net Cashflow Rs m1441,328 10.8%  

Share Holding

Indian Promoters % 69.1 27.4 252.3%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 19.0 38.9 48.9%  
FIIs % 4.5 19.5 23.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 72.6 41.9%  
Shareholders   85,212 91,182 93.5%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs STRIDES PHARMA SCIENCE Share Price Performance

Period ALEMBIC PHARMA STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day -0.15% 1.16% 1.18%
1-Month -4.30% 0.35% -0.75%
1-Year 105.43% 176.88% 61.82%
3-Year CAGR 0.89% -3.35% 18.16%
5-Year CAGR 13.56% 10.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 46.0%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.